Stephen G. Madison, BSc.Pharm, RPh, MBA, CHCP
President and CEO
Oncology Learning Center, Inc., and the
BioMedical Learning Institute
Owner of InsiderMD, CPLS, Steve Madison Cancer Consulting, Oncology Insights, and Cancer Comm®
Stephen G. Madison, BSc.Pharm, RPh, MBA, CHCP top
Steve Madison has been involved with the science and business of oncology/hematology since 1983. He started his career in the field of oncology and hematology as an oncology pharmacist, employed as a pharmaceutical industry marketing executive of Bristol-Myers (BM) for the BM oncology products starting in 1983 as one of only two international marketing executives within BM. In 1983, there were only three cancer pharmaceutical companies in the USA: Bristol-Myers (BM), Mead Johnson and Adria Laboratories. Steve was fortunate to have started establishing working relationships with the academic (“KOL”) leaders in oncology and hematology at the beginning of the oncology business era, 36 years ago. And to this day in 2016, Steve has maintained his important KOL relationships beginning with his employment at Bristol-Myers, but also through his subsequent cancer education and medical advertising companies as described below.
In 1994 Steve left Bristol-Myers and founded and operated, SG Madison & Associates, a global medical/marketing communications and advertising company, which as agency of record, helped successfully launch gemcitabine, trastuzumab, rituximab, cetuximab, and several other oncology and HIV products; but primarily Steve and his medical/marketing company supported the oncology & HIV franchises of Bristol-Myers (eventually Bristol-Myers Squibb) in the US and Globally, plus the businesses of ImClone, Genentech, Lilly and several other companies not on a retainer basis.
In 1999 Steve founded the first of his two CME/CE accredited companies: the CBCE (Center for Biomedical Continuing Education) which he sold in 2001 along with his medical/marketing communications agency, SG Madison & Associates. During his tenure at his two CME/CE companies and SG Madison & Associates, Steve founded several major ongoing cancer education meetings and symposia, and at least two of which are still ongoing today, including the now 17th Annual Anti-Angiogenic Symposium held each year in La Jolla, CA, sponsored by MD Anderson Cancer Center and co-chaired by Dr. George Sledge and Lee Ellis, the now 17th Annual Targeted Therapies for Lung Cancer Meeting, held each year in Santa Monica, CA, sponsored by the IASLC co-chaired by Drs. Paul Bunn, Roy Herbst, Dave Johnson and Fred Hirsch.
In 2006 Steve founded the Oncology Learning Center, Inc., (also operated as the BioMedical Learning Institute) which conducts numerous live and Web-based oncology/hematology educational CME/CE activities, including annual satellite CME/CE symposia at the annual meetings of the American Society of Clinical Oncology, the American Society of Hematology, the San Antonio Breast Cancer Symposium, the Oncology Nursing Society and many other meetings and congresses, and including of its own, stand-alone educational events (of the BLMI) including the annual Symposium on Personalized Therapies and Best Clinical Practices for lung Cancer now in its 9th consecutive year, and its 1st Annual Symposium on Integrating Immune Therapy and Targeted Therapy into Standards of Care for Hematologic and Solid Malignancies to be held on September 10, 2016 in San Francisco.
In addition, Steve and the Oncology Learning Center have now resumed the highly successful Cancer Master Classes that were suspended in 2005, beginning with the October 19-21, 2016 Strategic Cancer Business Master Class and Other Master Classes will follow shortly. Please see: www.OncologyLearningCenter.com
Finally, Steve owns but does not (presently) operate several other cancer businesses of importance to pharmaceutical and diagnostic/laboratory companies, including his cancer consulting company, Steve Madison Cancer Consulting, as well as his oncology KOL development company: InsiderMD.com; his customized oncology training company: CPLS.com (Customized Pharmaceutical Learning Systems), and also his customized cancer market research company: Oncology Insights.com. The reason for Steve’s lack of involvement (for the present), is the 2009 legislation prohibiting his participation in both CME and non CME companies. It is anticipated that this will change in the very near future as Steve his other executives to operate his CME business, thus enabling Steve to operate freely inside his non-CME businesses: InsiderMD.com, CPLS.com (Customized Pharmaceutical Learning Systems), Steve Madison Consulting.com and Oncology Insights.com. Should anyone be interested in any of these business or their services please contact Steve.Madison@CPLS.com.